PodParley PodParley
JIMD Podcasts cover art

All Episodes

JIMD Podcasts — 260 episodes

#
Title
1

Metabolic Mysteries: Recurrent abdominal pain, “FMF” and attacks around menstruation

2

Tyrosine Hydroxylase Deficiency: Consensus guidelines

3

Shortcast: Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

4

D-Glyceric aciduria: is GLYCTK really mitochondrial?

5

Shortcast: Drivers of Diagnostic Delay in Mito Disease: Missed Recognition of Canonical Features

6

mRNA therapies in liver Inherited Metabolic Diseases

7

Shortcast: Epilepsy Phenotype and EEG Finding of RHADS in Succinate Dehydrogenase Deficiency

8

Beyond Triheptanoin: Elamipretide and Cardiolipin Remodeling in TFP Deficiency

9

Shortcast: Treatable Neonatal MoCD Type A: Rapid Demise Despite Rapid Biochemical Diagnosis

10

Personalized metabolic modeling in Methylmalonic Aciduria

11

Shortcast: Holocarboxylase Synthetase Deficiency: Second Case Report With Neonatal Cholestasis

12

Vitamin and Cofactor Prescribing in Primary Mitochondrial Disease

13

Shortcast: Fulminant Metabolic Crisis in GSDIa: Persistent Lactic Acidosis Despite Hypo Correction

14

Palliative care in inherited metabolic disease: an underutilised but essential service

15

Shortcast: A Multisystem Perspective of Pediatric Cell Trafficking Disorders: Within the Cells, Beneath the Signs

16

Manganese transporter disorders: diagnosis and treatment

17

Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants

18

Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff

19

Continuous Glucose Monitoring in hepatic GSDs

20

Metabolic mysteries: Developmental delay, hepatoblastoma and a VUS

21

Biomarkers in Niemann-Pick type C: Preparing for Clinical Trials

22

Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders

23

Chenodeoxycholic acid in Cerebrotendinous Xanthomatosis

24

IMD Research Round-Up: Mitochondrial disease

25

First in human gene editing: a new era for IMD therapies

26

Metabolic mysteries: A 61-year-old with rhabdomyolysis and lifelong episodic fatigue

27

Geriatric IMD: Diagnosing inherited metabolic disorders in older adults

28

IMD Research Round-Up: Untargeted metabolomics

29

Pharmacological chaperones in OTC deficiency

30

Shortcast: Clinical and Developmental Outcomes after 50 Years of Galactosaemia NBS in Ireland

31

Penetrance, expressivity, and outcomes in classic galactosemia

32

IMD Research Round-Up: Lysosomal Storage Disorders

33

Adenosine Kinase

34

Footprints of IMD: Movement Disorders... with Dakota Peacock and Darius Ebrahimi-Fakhari

35

Metabolic mysteries: Incidental adrenal calcifications in a neonate

36

The treatment landscape in CDG

37

IMD Research Round-Up: Newborn Screening

38

ARS1 Deficiencies

39

Shortcast: Investigating the utility of leukocyte sialic acid measurements in Lysosomal FSASD

40

Diagnostic delay in Metachromatic Leukodystrophy

41

IMD Research Round-Up: Glycogen Storage Disorders

42

Future therapies in galactosemia

43

Metabolic mysteries: GI bleeding, gallbladder polyps and evolving developmental delay

44

Speech and Language in Batten disease

45

Metabolic Minds 2025

46

IMD Research Round-Up: Redox metabolism

47

ECHS1 deficiency and valine restriction

48

Metabolic mysteries: A child with episodic seizures and multiple diagnoses

49

Managing Metabolic Emergencies - Intoxication type disorders

50

IEMs in Adult Metabolic Centres: 10 Years Later

51

IMD Research Round-Up: Methylmalonic Aciduria

52

Shortcast: Sleep quality in children with hepatic GSDs, a prospective observational pilot study

53

NAXD deficiency

54

Imaging readiness in the gene therapy era

55

IMD Research Round-Up: Congenital Disorders of Glycosylation

56

Exploring the disease burden in Arginase 1 deficiency

57

Shortcast: D,L-3-hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS)

58

Citrulline: beyond the urea cycle

59

Metabolic mysteries: Hypoglycemia? Don't forget the urine

60

Metabolic mysteries: New weakness, poor balance and paresthesia at 55 years of age

61

Transition & executive function in MSUD

62

Shortcast: TFP deficiency caused by a deep intronic deletion leading to aberrant splicing

63

CBS Deficiency in the E-HOD Registry

64

The Treatabolome: Don't miss the chance to treat!

65

Velmanase alfa for alpha-mannosidosis

66

An update on autophagy disorders

67

Models in Leigh Syndrome

68

KAMPER: Kuvan (BH4) in phenylketonuria

69

Dietary management in GSD type 3a

70

Footprints of IMD: Psychiatric presentations... with Gabriella Horvath

71

Shortcast: Two successful pregnancies in patients taking Volanesorsen for FCS

72

RNA based therapies in Urea Cycle Disorders

73

Brain changes in infantile Pompe disease

74

Shortcast: Metabolic management of a successful pregnancy in FBPase deficiency

75

Gene therapy for mitochondrial disorders

76

Adult outcomes in classic galactosemia

77

Footprints of IMD: Metabolic cardiovascular disease... with Carlos Ferreira

78

Neuronopathic gaucher disease

79

Chorioretinopathy In LCHADD

80

Footprints of IMD: Metabolic myopathies... with Corrado Angelini

81

Flies, plants and classic galactosemia

82

Shortcast: Do early-treated adults with phenylketonuria sense high phenylalanine levels?

83

Fatty acid homeostasis

84

Metabolic mysteries: Progressive neurological symptoms after a change in diet

85

Heterozygous DHDDS variants

86

Footprints of IMD: Metabolic Epilepsies... with Phillip Pearl

87

Gene replacement therapies for inherited disorders of neurotransmission: Progress in SSADH

88

Shortcast: Galactokinase 1 is the source of elevated gal-1-phosphate in a galactosemia mouse model

89

Dietary management for pyridoxine-dependent epilepsy

90

Footprints of IMD: Metabolic Liver Disease... with David Cassiman

91

Shortcast: Normal transferrin glycosylation does not rule out severe ALG1 deficiency

92

Speech & neural oscillation in classic galactosemia

93

Shortcast: Late-onset refractory hemolytic anemia in siblings treated for MTRR deficiency

94

Lessons from adult metabolic medicine

95

Metabolic mysteries: A treatable condition masquerading as TORCH Infection

96

Footprints of IMD: the IEMbase and Cerebral Palsy... with Gabriella Horvath

97

Pregnancy in phenylketonuria

98

Acute liver failure? Think metabolic

99

Aicardi-Goutières syndrome

100

Shortcast: Pediatric palliative care for IMD: 20-year survey of outpatients at a Brazilian hospital

101

Pregnancy in Urea Cycle Disorders

102

Shortcast: Clinical experience with glycerol phenylbutyrate in 20 patients with UCDs

103

Liver directed gene therapy

104

Shortcast: Psychosocial issues and coping strategies in families affected by long-chain FAOD

105

BH4 in tyrosine hydroxylase deficiency

106

Shortcast: Lysinuric protein intolerance exhibiting RTA/Fanconi syndrome in a Japanese woman

107

How to proceed after a "negative" exome

108

Shortcast: Neuropsychological stability in classical galactosemia: A pilot study in 10 adults

109

Food or medicine? Nutritional therapies in IMD

110

Metabolic mysteries: Three children with neurological symptoms and coagulopathy

111

Movement disorders and mRNA therapy in Arginosuccinic aciduria

112

Metabolic mysteries: Recurrent miscarriage and congenital anomalies

113

Hepatic presentations in mitochondrial depletion syndromes

114

Shortcast: Lysosomal storage disorders identified in adult population from India

115

Genomic newborn screening: are we entering a new era of screening?

116

Shortcast: A case of hyperlysinemia identified by urine newborn screening

117

JIMD Editor's Roundtable (2023)

118

Shortcast: Relationship between plasma & capillary blood Phe using volumetric collection devices

119

Deciphering pathogenicity with CRISPR/Cas9

120

Shortcast: Grip strength in patients with galactosemia and in a GALT-null rat model

121

Gene therapy in Glycogen Storage Disorders

122

Shortcast: Screening data for 19 patients with late-onset Pompe disease for a phase I clinical trial

123

CAD deficiency: Beyond the genetics

124

Shortcast: Diagnosis and management of children with McArdle Syndrome (GSD V) in New South Wales

125

Shortcast: PIGO-CDG: A case study, phenotypic expansion, lit review, and nosological considerations

126

Comorbidity in acute porphyria

127

Metabolic mysteries: Post-partum ataxia and confusion

128

Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD

129

An oral enzyme therapy for MSUD

130

Shortcast: Comparison of subcutaneous and intravenous moss-aGal in Fabry disease mouse model

131

Metabolic mysteries: A child with dystonia and MRI changes

132

Fetal gene therapy

133

Shortcast: Interstitial lung disease and pancreatic exocrine insufficiency in CADDS

134

SSIEM 2022 special episode

135

Gene therapy in urea cycle disorders: a historical perspective and future prospects

136

Possible substrate reduction therapy in disorders of valine and isoleucine metabolism

137

Shortcast: Prolonged respiratory failure treatment in isolated homocysteine remethylation defects

138

A clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency

139

Shortcast: Expanding the phenotypic and genotypic spectrum of CARS2-related mitochondrial disease

140

Pregnancy in acute porphyria

141

Gene therapies in mucopolysaccharidoses

142

Shortcast: Neonatal presentation of occipital horn syndrome caused by a ATP7A missense variant

143

Racial diversity and the S135L variant in galactosemia

144

Shortcast: Increased prevalence of Parkinson's disease in alkaptonuria

145

Shortcast: Late infantile & adult-onset MLD due to novel missense variants in the PSAP gene

146

Gene therapy in a mouse model of MSUD

147

Key terms and definitions In porphyria

148

PGM1-CDG: isoforms, phenotyping and gene therapy

149

A novel UHPLC/HRAM MS approach in LSD screening

150

Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity

151

Cholestasis, oxysterols and clinical conundrums

152

Shortcast: The remarkable journey of one female individual with OTC deficiency diagnosed post-mortem

153

Fractionated plasma N-glycan profiling and ATP6AP1 - CDG

154

Shortcast: Autonomic instability, arrhythmia & visual impairment in MTFMT related mito disease

155

B vitamins, drosophila and TANGO2-deficiency disorder

156

Shortcast: Paracetamol toxicity in classic HCU: Effect of N-acetylcysteine on total homocysteine

157

The complex machinery of cobalamin

158

Shortcast: MOGS-CDG: Quantitative analysis of a diagnostic biomarker & phenotype of 6 new cases

159

How guidelines drive research and research influences guidelines

160

Shortcast: Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency

161

Shortcast: First decade anniversary of the United Kingdom National Alkaptonuria Centre

162

Cellular Insights and Computational Modelling In MMA

163

Novel therapy in a propionic acidemia mouse model

164

Shortcast: Compound heterozygous variants in 2 sialyltransferase ST3GAL5 motifs cause GM3SD

165

Shortcast: 3-Methylglutaconyl-CoA hydratase deficiency: Ascertainment bias vs biochemical diagnosis

166

Priority Setting Partnership in Mitochondrial Disease

167

Shortcast: HPMRS3 (Mabry Syndrome): CSF abnormalities and correction with pyridoxine & Folinic acid

168

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: 3rd revision

169

Diagnostics, EXPLORE B and POWER in Porphyria

170

Shortcast: Isolated neurological presentations of mevalonate kinase deficiency

171

Novel CSF biomarkers in GLUT1 deficiency syndrome

172

Shortcast: Management of pregnancy in a patient with LCHADD

173

Shortcast: Infantile-onset Pompe disease with neutropenia

174

Sex Specific Screening in X-linked Adrenoleucodystrophy

175

Shortcast: Direct replacement of oral benzoate with glycerol phenylbutyrate in children with UCD

176

Everyone's talking about empagliflozin

177

Shortcast: GA 1: Diagnosis, clinical features & long-term outcome in a cohort of 34 Irish patients

178

Shortcast: Use of Elamipretide in patients assigned treatment in the compassionate use program

179

Genomic Therapies In IMD: Lessons from MMA

180

Shortcast: Transcriptomic study in explanted liver from a patient with acute intermittent porphyria

181

Shortcast: Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III

182

Moving towards management guidelines in ALG8 - CDG

183

Shortcast: Alternative sources of valine and isoleucine for prompt leucine reduction in MSUD

184

Shortcast: N-acetylglutamate synthase deficiency with associated 3-methylglutaconic aciduria

185

Eye movement disorders in Inherited Metabolic Disease

186

Shortcast: The prevalence of inherited metabolic disorders in the Estonian population over 30 years

187

Shortcast: Respiratory chain dysfunction in a patient with a heterozygous de novo CTBP1 variant

188

The doxycycline paradox in mitochondrial disease

189

Training in Adult Metabolic Medicine

190

Shortcast: A cross-sectional natural history study of aspartylglucosaminuria

191

Diagnosis and Discovery: Insights from the Undiagnosed Diseases Program

192

Future Therapies in Galactosaemia

193

Mitochondrial Trifunctional Protein Deficiency

194

Reproductive Genetic Carrier Screening in IMD

195

Glitazones in X-linked adrenoleukodystrophy

196

Betaine in early onset MTHFR Deficiency

197

Shortcast: Clinical spectrum of early onset “Mediterranean” MNGIE

198

Gls2 knockdown - a different approach for Urea Cycle Disorders?

199

Shortcast: Glycogen storage disease type IIIa in pregnant women

200

Lost in translation — Challenges in drug development for rare disease

201

Machine learning in newborn screening

202

Barth Syndrome (part 2): Screening, modelling and more

203

Barth Syndrome (part 1): Disease overview and future treatments

204

CDG or not CDG

205

Shortcast: High penetrance and recurrent attacks in a family with hereditary coproporphyria

206

Dentistry in Inherited Metabolic Disease

207

Shortcast: Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort

208

Shortcast: A serendipitous journey to a promoter variant in OTC

209

NGLY1 deficiency & epilepsy

210

Molybdenum Cofactor Deficiency

211

Shortcast: Chondroitin sulfate disaccharide as a biomarker for MPS IVA

212

Shortcast: A mild phenotype of mitochondrial trifunctional protein deficiency

213

Treatment In Alkaptonuria

214

Shortcast: Acute and early developmental outcomes of children with Duarte galactosemia

215

Arginase Deficiency

216

Shortcast: Two siblings with galactose mutarotase deficiency: Clinical differences

217

AAV-gene therapy in galactosemia patient fibroblasts

218

Unravelling the Secrets Of PMM2-CDG

219

Transplant Outcomes in X-ALD

220

Positive Negatives - genistein and resveratrol

221

100 Years Of IMD (in Austria)

222

Mitochondrial Disease Special Issue: Novel Therapies

223

Organoids in IMD

224

MPS 1: Where are we now?

225

Easy as ABC...D3

226

Assembling the treatment puzzle in Niemann Pick C

227

McArdle disease - expanding the clinical phenotype

228

Gene Therapy in CBS Deficiency

229

Cognitive and psychosocial outcomes in early-treated PKU

230

Disease Or Disorder: New Insights in Valine Degradation

231

Inborn Errors of the Malate Aspartate Shuttle

232

The Young Metabolists Society

233

Why everyone needs to know about Urea Cycle Disorders

234

Treatment In Lysosomal Storage Disorders

235

An International Classification of Inherited Metabolic Disorders

236

Emergency Protocol.net

237

N-glycome analysis in Congenital Disorders of Glycosylation

238

Galactosemia: An old diagnosis with new ideas

239

Diagnosis and management of methylmalonic acidaemia and propionic acidaemia

240

Transplantation in IMD

241

LSD Heterozygosity and Neurodegenerative Disease

242

Everything about Alkaptonuria

243

A narrative review of GSD III

244

ATP6V1A related metabolic cutis laxa

245

All About ALD

246

Pyridoxine-dependent epilepsy

247

Talking about Triheptanoin

248

It takes two to TANGO2

249

Characterising late-onset MTHFR deficiency

250

Best Of JIMD Reports

251

MSD: The diagnosis needs the patients

252

Taking a position on MNGIE

253

Newborn screening: To WES or not to WES

254

Ketogenic diets in inherited metabolic disease

255

Towards Trials in Mitochondrial Disease

256

PGM1-CDG with Professor Morava

257

Simplifying Inherited Metabolic Disease

258

IMD and Susceptibility to COVID19

259

Mitochondria, medication and POLG

260

PKU And Ageing